These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 25503143

  • 1. Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicin.
    Stojak M, Lukawska M, Oszczapowicz I, Opydo-Chanek M, Mazur L.
    Anticancer Res; 2014 Dec; 34(12):7151-8. PubMed ID: 25503143
    [Abstract] [Full Text] [Related]

  • 2. In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin.
    Stojak M, Mazur L, Opydo-Chanek M, Lukawska M, Oszczapowicz I.
    Anticancer Res; 2013 Oct; 33(10):4439-43. PubMed ID: 24123013
    [Abstract] [Full Text] [Related]

  • 3. Effects of structural modifications of daunorubicin on in vitro antileukemic activity.
    Stojak M, Mazur L, Opydo-Chanek M, Lukawska M, Oszczapowicz I.
    Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426
    [Abstract] [Full Text] [Related]

  • 4. Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia.
    Al-Aamri HM, Ku H, Irving HR, Tucci J, Meehan-Andrews T, Bradley C.
    BMC Cancer; 2019 Feb 27; 19(1):179. PubMed ID: 30813936
    [Abstract] [Full Text] [Related]

  • 5. In Vitro Antileukemic Activity of Formamidine Epidoxorubicin Analogs.
    Mazur L, Opydo-Chanek M, Śladowska K, Janota B, Kłaput U, Łukawska M, Oszczapowicz I.
    Anticancer Res; 2017 Nov 27; 37(11):6363-6372. PubMed ID: 29061821
    [Abstract] [Full Text] [Related]

  • 6. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells.
    Nakaoka E, Tanaka S, Onda K, Sugiyama K, Hirano T.
    Anticancer Res; 2015 Nov 27; 35(11):6041-8. PubMed ID: 26504027
    [Abstract] [Full Text] [Related]

  • 7. Pleiotropic effects of spongean alkaloids on mechanisms of cell death, cell cycle progression and DNA damage response (DDR) of acute myeloid leukemia (AML) cells.
    Stuhldreier F, Kassel S, Schumacher L, Wesselborg S, Proksch P, Fritz G.
    Cancer Lett; 2015 May 28; 361(1):39-48. PubMed ID: 25697484
    [Abstract] [Full Text] [Related]

  • 8. Relationship between daunorubicin concentration and apoptosis induction in leukemic cells.
    Masquelier M, Zhou QF, Gruber A, Vitols S.
    Biochem Pharmacol; 2004 Mar 15; 67(6):1047-56. PubMed ID: 15006541
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Feb 15; 51(2):119-26. PubMed ID: 12647012
    [Abstract] [Full Text] [Related]

  • 10. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
    Perchellet EM, Magill MJ, Huang X, Dalke DM, Hua DH, Perchellet JP.
    Anticancer Drugs; 2000 Jun 15; 11(5):339-52. PubMed ID: 10912950
    [Abstract] [Full Text] [Related]

  • 11. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM, Sperfslage BJ, McIlvain CJ, Aligiannis N, Pouli N, Marakos P, Skaltsounis AL, Perchellet JP.
    Anticancer Res; 2001 Jun 15; 21(6A):3957-67. PubMed ID: 11911277
    [Abstract] [Full Text] [Related]

  • 12. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia].
    Zhou RQ, Gong YP, Zheng BH, Yang X.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep 15; 41(5):789-92. PubMed ID: 21302442
    [Abstract] [Full Text] [Related]

  • 13. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Jul 15; 52(1):47-58. PubMed ID: 12750841
    [Abstract] [Full Text] [Related]

  • 14. Biological properties of new derivatives of daunorubicin.
    Wasowska-Lukawska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I.
    In Vivo; 2007 Jul 15; 21(2):413-6. PubMed ID: 17436596
    [Abstract] [Full Text] [Related]

  • 15. Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis.
    Mansilla S, Piña B, Portugal J.
    Biochem J; 2003 Jun 15; 372(Pt 3):703-11. PubMed ID: 12656675
    [Abstract] [Full Text] [Related]

  • 16. Plant-derived abrin-a induces apoptosis in cultured leukemic cell lines by different mechanisms.
    Ohba H, Moriwaki S, Bakalova R, Yasuda S, Yamasaki N.
    Toxicol Appl Pharmacol; 2004 Mar 01; 195(2):182-93. PubMed ID: 14998684
    [Abstract] [Full Text] [Related]

  • 17. Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment.
    Al-Aamri HM, Irving HR, Bradley C, Meehan-Andrews T.
    BMC Cancer; 2021 Apr 21; 21(1):438. PubMed ID: 33879127
    [Abstract] [Full Text] [Related]

  • 18. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.
    Pogrebniak A, Schemainda I, Azzam K, Pelka-Fleischer R, Nüssler V, Hasmann M.
    Eur J Med Res; 2006 Aug 30; 11(8):313-21. PubMed ID: 17052966
    [Abstract] [Full Text] [Related]

  • 19. [The anti-leukemic effects of imatinib, daunorubicin and bortezomib on two leukemia cell lines with Ph(+)].
    Yang X, Yang L, Gong YP, Chang H, Zhou RQ, Xing HY, Zheng BH.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep 30; 41(5):793-6. PubMed ID: 21302443
    [Abstract] [Full Text] [Related]

  • 20. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
    Perchellet EM, Sperfslage BJ, Wang Y, Huang X, Tamura M, Hua DH, Perchellet JP.
    Anticancer Drugs; 2002 Jul 30; 13(6):567-81. PubMed ID: 12172502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.